ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

GLUE Company Profile and Key Details

NASDAQ : GLUE

Monte Rosa Therapeutics, Inc.

$4.06

0.105+2.66%

At Close 4:00 PM

68.69

B-ESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

GLUE Stock Price Chart

Stock Price Today

Monte Rosa Therapeutics, Inc. (GLUE) stock surged +2.66%, trading at $4.06 on NASDAQ, up from the previous close of $3.95. The stock opened at $3.64, fluctuating between $3.50 and $4.09 in the recent session.

Stock Snapshot

3.95

Prev. Close

3.64

Open

249.42M

Market Cap

61.51M

Number of Shares

3.5001

Day Low

4.09

Day High

-4.14

P/E Ratio

74.77%

Free Float in %

-0.98

EPS (TTM)

3.15

Book Value

-1.1

Cash Flow per Share

895.43K

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 07, 2025	3.64	4.09	3.50	4.06	895.43K
Apr 04, 2025	3.69	3.97	3.65	3.95	1.14M
Apr 03, 2025	4.17	4.24	3.88	3.89	972.79K
Apr 02, 2025	4.33	4.67	4.28	4.41	572.43K
Apr 01, 2025	4.57	4.64	4.33	4.42	717.57K
Mar 31, 2025	4.88	4.96	4.50	4.64	756.33K
Mar 28, 2025	5.25	5.27	5.01	5.10	587.05K
Mar 27, 2025	5.47	5.55	5.13	5.26	642.65K
Mar 26, 2025	5.82	5.95	5.39	5.49	698.63K
Mar 25, 2025	5.83	5.87	5.48	5.67	681.9K
Mar 24, 2025	5.85	5.91	5.55	5.83	843.14K
Mar 21, 2025	7.05	7.14	5.60	5.80	2.13M
Mar 20, 2025	6.46	7.31	6.44	7.06	2.47M
Mar 19, 2025	6.67	6.91	6.38	6.70	824.33K
Mar 18, 2025	6.55	6.83	6.42	6.67	835.66K
Mar 17, 2025	6.32	7.00	6.17	6.73	592.7K
Mar 14, 2025	6.29	6.42	6.12	6.27	544.31K
Mar 13, 2025	6.57	6.67	6.19	6.21	311.42K
Mar 12, 2025	6.25	6.70	6.20	6.64	425.04K
Mar 11, 2025	6.03	6.21	5.80	6.11	426.7K

Contact Details

Boston, MA 02210

United States

Website: https://www.monterosatx.comContact: 617 949 2643

About Company

Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing protein for the treatment of Myc-driven cancers. The company also develops CDK2 to treat ovarian, uterine, and breast cancers; NEK7 for the treatment of inflammatory diseases, such as Crohn's disease, neurodegenerative disease, diabetes, and liver disease; VAV1, a target protein for autoimmune diseases; and BCL11A, a therapeutically-relevant protein in hemoglobinopathies. Monte Rosa Therapeutics, Inc. was incorporated in 2019 and is headquartered in Boston, Massachusetts.

Frequently Asked Questions

What is the current Monte Rosa Therapeutics, Inc. (GLUE) stock price?

Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE) stock price is $4.06 in the last trading session. During the trading session, GLUE stock reached the peak price of $4.09 while $3.50 was the lowest point it dropped to. The percentage change in GLUE stock occurred in the recent session was 2.66% while the dollar amount for the price change in GLUE stock was $0.11.

GLUE's industry and sector of operation?

The NASDAQ listed GLUE is part of Biotechnology industry that operates in the broader Healthcare sector. Monte Rosa Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of GLUE?

Dr. Markus Warmuth M.D.
Pres, Chief Executive Officer & Director
Dr. Filip Janku M.D., Ph.D.
Chief Medical Officer
Dr. Sharon Townson Ph.D.
Chief Technology Officer
Dr. Owen B. Wallace Ph.D.
Chief Scientific Officer
Mr. Magnus Walter DPHIL
Senior Vice President of Chemical Sciences & Process Devel.
Dr. John C. Castle Ph.D.
Chief Data Scientist
Ms. Jennifer Champoux
Chief People & Operations Officer
Dr. Jullian G. Jones J.D., M.B.A., Ph.D.
Chief Bus. Officer
Mr. Ajim A. Tamboli C.F.A.
Chief Financial Officer
Mr. Phil Nickson J.D., Ph.D.
Gen. Counsel
Dr. Silvia Buonamici Ph.D.
Senior Vice President of Drug Discovery Biology
Mr. Philip Nickson J.D., Ph.D.
Gen. Counsel

How GLUE did perform over past 52-week?

GLUE's closing price is 26.32% higher than its 52-week low of $3.21 where as its distance from 52-week high of $12.40 is -67.3%.

How many employees does GLUE have?

Number of GLUE employees currently stands at 134.

Link for GLUE official website?

Official Website of GLUE is: https://www.monterosatx.com

How do I contact GLUE?

GLUE could be contacted at phone 617 949 2643 and can also be accessed through its website. GLUE operates from 645 Summer Street, Boston, MA 02210, United States.

How many shares of GLUE are traded daily?

GLUE stock volume for the day was 895.43K shares. The average number of GLUE shares traded daily for last 3 months was 705.33K.

What is the market cap of GLUE currently?

The market value of GLUE currently stands at $249.42M with its latest stock price at $4.06 and 61.51M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

Employees	134
Beta	1.5
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology